
Diabetes & Endocrinologycatecholaminessomatostatin receptor therapy
Octreotide in the Management of Catecholamine-Secreting Pheochromocytomas and Paragangliomas: A Promising Adjunctive Therapy
By MedXY|Aug 22, 2026
Octreotide shows potential as an effective adjunctive therapy in catecholamine-secreting pheochromocytomas and paragangliomas, improving biochemical, hemodynamic, and metabolic parameters and supporting perioperative management.